Market Entry Strategy
Navigating New Market Opportunities
A client looking to expand into a new market needed a tailored market entry strategy. Our team conducted in-depth market research, competitor analysis, and customer segmentation to guide the entry process.
We crafted a roadmap that outlined the optimal entry strategy, identified potential partners, and evaluated key risks. This helped the client successfully enter the market, build brand recognition, and establish a foothold in a competitive space.
Project conducted by: Randy
Client: A digital pathology startup
Objective: Provide an SaMD client (AI biomarker prediction → precision therapy) a clear reimbursement strategy and detailed implementation plan.
Randy evaluated critical decision points that can lead to a delay to market, as related to FDA (pre-)submission, CLIA lab buy-borrow-build, pursuance of ADLT status, and AMA CPT coding.
Other Deliverables:
- In-depth HCP (oncologist/pathologist/Lab Director/COO) interviews
- Advised on CLIA/no-CLIA reimbursement strategy after engaging the key government regulator
- Financial modelling for purchase incentivization of hospital central labs
Outcome: Client pursued the recommendations to (1) raise additional VC funds, (2) build a 2-year go-to-market plan, (3) tailor their sales strategy, and (4) pursue a hospital billing pathway.